SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-17-103621
Filing Date
2017-03-30
Accepted
2017-03-30 13:39:57
Documents
63
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d312455d10k.htm 10-K 740710
2 EX-3.1 d312455dex31.htm EX-3.1 293001
3 EX-23.1 d312455dex231.htm EX-23.1 3620
4 EX-31.1 d312455dex311.htm EX-31.1 9063
5 EX-31.2 d312455dex312.htm EX-31.2 8490
6 EX-32.1 d312455dex321.htm EX-32.1 4298
  Complete submission text file 0001193125-17-103621.txt   3559921

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT oxgn-20161231.xml EX-101.INS 520384
8 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20161231.xsd EX-101.SCH 39051
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20161231_cal.xml EX-101.CAL 48600
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20161231_def.xml EX-101.DEF 100645
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20161231_lab.xml EX-101.LAB 328576
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20161231_pre.xml EX-101.PRE 217251
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 17724830
SIC: 2836 Biological Products, (No Diagnostic Substances)